Organometal halide perovskites quantum dots (OHP-QDs) with bright, color-tunable, and narrow-band photoluminescence have significant advantages in display, lighting, and laser applications. Due to sparse concentrations and difficulties in the enrichment of OHP-QDs, production of large-area uniform films of OHP-QDs is a challenging task, which largely impedes their use in electroluminescence devices. Here, a simple dip-coating method has been reported to effectively fabricate large-area uniform films of OHP-QDs. Using this technique, multicolor OHP-QDs light-emitting diodes (OQ-LEDs) emitting in blue, blue-green, green, orange, and red color have been successfully produced by simply tuning the halide composition or size of QDs. The blue, green, and red OQ-LEDs exhibited, respectively, a maximum luminance of 2673, 2398, and 986 cd m⁻² at a current efficiency of 4.01, 3.72, and 1.52 cd A⁻¹, and an external quantum efficiency of 1.38%, 1.06%, and 0.53%, which are much better than most LEDs based on OHP films. The packaged OQ-LEDs show long-term stability in air (humidity ≈50%) for at least 7 d. The results demonstrate the great potential of the dip-coating method to fabricate large-area uniform films for various QDs. The high-efficiency OQ-LEDs also demonstrate the promising potential of OHP-QDs for low-cost display, lighting, and optical communication applications.

Combination of chemotherapy and photothermal therapy is considered to be a promising strategy for the next generation of cancer treatments. However, it has been limited by difficulties in obtaining high drug payload chemo-photothermal agents, and thus complete destruction of tumor without recurrence has never been achieved, unless they are conjugated with some targeting ligands for special targeted drug delivery. Herein, iron oxide nanoparticle (IONP)-doped 10-hydroxycamptothecin drug nanorods (HCPT NRs), with an organic conducting polymer poly(4-styrenesulfonate) (PEDOT) coating outside, are developed for cancer diagnosis and chemo-photothermal therapy. The drug-loading capacity of HCPT in the complex NRs reaches up to 72%, which is much higher than previously reported carrier-based nanocomposites. In vitro studies show that the resulting NRs demonstrate an excellent chemo-photothermal synergistic effect for tumor ablation. More importantly, 100% in vivo tumor elimination is achieved under a low laser power density of 1 W cm⁻² without weight loss and tumor recurrence. Moreover, IONP endow these drug nanocomposites with imaging capabilities, thus rendering the resulting HCPT-PEDOT NR an all-in-one processing system for diagnosis and treatment with low systematic toxicity.

Gold (Au)-nanoshelled 10-hydroxycamptothecin nanoparticles (HCPT NPs) are developed with combination of photothermal therapy and chemotherapy for highly effective cancer therapy. The strong near-infrared (NIR) absorbance from Au nanoshells endows the nanocomposites photothermal effects and on-demand drug release. Notably, the drug-loading content reaches up to 63.7 wt%, which is much higher than that in the previously reported nanovehicles systems. Both in vitro and in vivo studies indicate that the combined local specific chemotherapy with external NIR photothermal therapy demonstrates a synergistic effect, which is significantly better than either of them alone. More importantly, due to the high drug-loading content and efficient photothermal effects of the nanocomposites, 100% in vivo tumor elimination is achieved at a low laser irradiation power density of 1 W cm⁻² without weight loss and tumor recurrence. No obvious systematic toxicity is observed for the injected mice, indicating the good biocompatibility of this kind of multifunctional drug nanocomposites. This work highlights the great potential of drug–nanostructure-based multifunctional core/shell nanpocomposite for highly efficient cancer therapy.